Bromodomain-containing protein 4 (BRD4): a key player in inflammatory bowel disease and potential to inspire epigenetic therapeutics
Author:
Affiliation:
1. Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA
2. Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA
Funder
Crohn’s & Colitis Foundation Entrepreneurial Investing (EI) Initiative award (J Zhou and B Tian), Litwin IBD Pioneers Program Award
Publisher
Informa UK Limited
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/14728222.2023.2175317
Reference61 articles.
1. Pathophysiology of Inflammatory Bowel Diseases
2. Microbiota dysbiosis in inflammatory bowel diseases: in silico investigation of the oxygen hypothesis
3. The risk of colorectal cancer in ulcerative colitis: a meta-analysis
4. Colorectal carcinoma and inflammatory bowel disease
5. Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. BRD4 absence inactivates endoplasmic reticulum stress to retard dehydroepiandrosterone-triggered ovarian granular cell apoptosis in polycystic ovary syndrome via GRP78;Tissue and Cell;2024-12
2. An updated patent review of BRD4 degraders;Expert Opinion on Therapeutic Patents;2024-09-04
3. Repression of BRD4 mitigates NLRP3 inflammasome-mediated pyroptosis in Mycobacterium-infected macrophages by repressing endoplasmic reticulum stress;Tuberculosis;2024-09
4. Effects of super-enhancers in cancer metastasis: mechanisms and therapeutic targets;Molecular Cancer;2024-06-07
5. Targeting BRD4 with PROTAC degrader ameliorates LPS-induced acute lung injury by inhibiting M1 alveolar macrophage polarization;International Immunopharmacology;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3